News and Announcements
Inside Healthcare Investing: How KP Rx is Transforming Australia’s Biotech Industry
- Published November 08, 2024 5:04AM UTC
- Publisher Maan Perez
- Categories Executive Interviews
Join us in this in-depth interview with Hashan De Silva, Founder of KP Rx, as he shares the journey behind launching a specialist healthcare VC firm. Learn how KP Rx is transforming biotech and medical device investments in Australia and New Zealand by capitalising on key market advantages. Hashan explains the firm’s unique approach, valuation arbitrage, and insights into healthcare investment strategies that have yielded significant success.
Executive Interviews
When Others Flee Biotech’s Winter, This Firm Sees Spring Around the Corner
In the midst of biotech’s downturn, a bold venture firm is seizing opportunities others overlook. Discover how Australia’s healthcare sector, fueled by government support and regulatory efficiency, is transforming into a biotech powerhouse.
Is the Innovation Bull Run Triggered?
Curious if we’re on the brink of an Innovation Bull Run? Key factors like interest rates, rising liquidity, increased investment, and market-driven election outcomes are all signals that could ignite market booms. Examining the Trump presidency’s impact on these elements sheds light on how today’s markets might be setting the stage for significant growth in innovative sectors.
Brain Vector’s Breakthrough in AI & VR for Mental Health: Personalised Therapy Solutions
Join us in an enlightening discussion with Dr. Stephane Verhaeghe, CEO & Co-Founder of Brain Vector, as he reveals the company’s groundbreaking use of AI and VR to support mental health. From aiding elderly patients in overcoming loneliness to assisting psychologists in creating customised therapy experiences, Brain Vector’s technology taps into positive memories to promote […]
Backed By Leading Investment Groups and Family Offices
